Microgynon®
Showing 1 - 25 of >10,000
Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and
Completed
- Contraception
- Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
- +2 more
- (no location specified)
Feb 2, 2022
Healthy Trial (BI 456906, Microgynon®)
Not yet recruiting
- Healthy
- BI 456906
- Microgynon®
- (no location specified)
Jun 14, 2023
Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)
Active, not recruiting
- Relapsing Multiple Sclerosis (RMS)
- Cladribine
- +2 more
-
Bochum, Germany
- +6 more
Feb 8, 2022
Healthy Trial in Mannheim (Microgynon®, BI 425809)
Recruiting
- Healthy
- Microgynon®
- BI 425809
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Jan 30, 2023
Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))
Recruiting
- Endometriosis Ovary
- Dienogest
- +3 more
-
Semarang, Central Java, IndonesiaKariadi Hospital
Nov 22, 2023
Therapeutic Equivalency Trial in Chennai (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Microgynon CD)
Completed
- Therapeutic Equivalency
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- Microgynon CD
-
Chennai, Tamil Nadu, IndiaAzidus Laboratories Ltd.
May 31, 2022
Migraine, Migraine;Menstrual Trial in Leiden (Ethinylestradiol/levonorgestrel, Vitamin E)
Recruiting
- Migraine
- Migraine;Menstrual
- Ethinylestradiol/levonorgestrel
- Vitamin E
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Apr 6, 2022
Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 1.34 mg/mL
- +4 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 3, 2022
Healthy Female Participants Trial in London (Padsevonil, Microgynon 30®)
Terminated
- Healthy Female Participants
- Padsevonil
- Microgynon 30®
-
London, United KingdomUp0035 001
Jun 22, 2021
Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and
Completed
- Bioequivalence
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
-
Santiago, ChileInnolab
Feb 8, 2021
Endometriotic Cyst of Ovary Trial (Letrozole, Placebo)
Not yet recruiting
- Endometriotic Cyst of Ovary
- Letrozole
- Placebo
- (no location specified)
Aug 2, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Ibrutinib
- +3 more
-
Krakow, Poland
- +3 more
Dec 3, 2019
Pharmacokinetics, Pharmacodynamics Trial in Moenchengladbach (laquinimod, Placebo)
Completed
- Pharmacokinetics
- Pharmacodynamics
- laquinimod
- Placebo
-
Moenchengladbach, GermanyTeva Investigational Site 32415
Nov 5, 2021
NSCLC Trial in Chemnitz (Microgynon, Nintedanib)
Terminated
- Carcinoma, Non-Small-Cell Lung
-
Chemnitz, GermanyKlinikum Chemnitz gGmbH
Nov 22, 2018
Clinical Trial ,Phase I Trial in Berlin (Vilaprisan (BAY 1002670), Vilaprisan Placebo, Microgynon)
Completed
- Clinical Trial ,Phase I
- Vilaprisan (BAY 1002670)
- +3 more
-
Berlin, Germany
- +1 more
Feb 27, 2019
Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,
Recruiting
- Atrial Fibrillation
- Heart rhythm measurements with Preventicus®
- +3 more
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Aug 28, 2023
ECMO Braile Biomédica® in COVID-19 Patients
Recruiting
- COVID-19
- Patients underwent cardiorespiratory support
-
Lago Sul, Brasília - DF, BrazilHospital Brasília
Oct 13, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)
Recruiting
- Venous Leg Ulcer
- Diabetic Foot
- AQUACEL® Ag+ Extra™
- Cutimed® Sorbact®
-
Barranquilla, Colombia
- +13 more
May 26, 2023
Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)
Recruiting
- Dental Implants
- Dynamic Computer Assisted Surgery
- Freehand
-
L´hospitalet de Llobregat, Catalunya, SpainUniversity of Barcelona
Aug 31, 2023
Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)
Completed
- Carpal Tunnel Syndrome
- KForce Sens
- Baseline Electrıgoniometer
-
Denizli, TurkeyPamukkale University
Sep 14, 2023
Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical
Not yet recruiting
- Tricuspid Regurgitation
- Tricuspid Valve Disease
- TricValve® Transcatheter Bicaval Valve System
- Medical Therapy Arm
-
Cleveland, Ohio
- +10 more
Nov 14, 2023
Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)
Recruiting
- Vaccine-Preventable Diseases
- +2 more
- Oral typhoid fever vaccine
- Oral cholera vaccine
-
Helsinki, FinlandMeilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023
Observatory on Cow's Milk Protein Allergy
Not yet recruiting
- Food Allergy
- Pepticate® Syneo®
-
Paris, FranceHôpital Trousseau - APHP
Oct 10, 2023